曲美木单抗
Tremelimumab (anti-CTLA-4)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg 50 mg 100 mg
Product Availability
3-5days
Price
$530.00
Member price
Product Availability
3-5days
Price
$1200.00
Member price
Product Availability
3-5days
Price
$1900.00
Member price
Product Availability
3-5days
Price
$6000.00
Member price
Product Availability
3-5days
Price
$12000.00
Member price
Quantity
- +
Product Overview
Product Name Tremelimumab (anti-CTLA-4)
CAS745013-59-6
Storage conditionStore at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Security information
Product details

Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and lung cancer.

Related literature
Related
Sorry, no related items
History
Tremelimumab (anti-CTLA-4)
Bimekizumab
Antioxidant 24 | Ultranox 626 | Bis(2,4-ditert-butylphenyl) pentaerythritol bisdiphosphite | Antioxidant 626
Lusutrombopag
Dess-Martin periodinane (DMP)
Aristoforin
Sotuletinib (BLZ945)
Dydrogesterone EP Impurity A;(9ß,10a)-Pregna-4,6,8(14)-triene-3,20-dione, 9ß,10a-Pregna-4,6,8(14)-triene-3,20-dione, Dydrogesterone Imp. A (EP)
Vincristine sulfate (Synonyms:Vincristine Sulphate; Leurocristine sulfate; NSC-67574 sulfate; 22-Oxovincaleukoblastine sulfate)
tert-butyl 2-(3-(2-aMino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yloxy)acetate